Works matching IS 10837159 AND DT 2010 AND VI 15 AND IP 2
Results: 16
Sorafenib therapy for hepatocellular carcinoma in an HIV-HCV coinfected patient: a case report.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Academia-pharma intersect: breast cancer. Lapatinib plus letrozole as first-line therapy for HER-2+ hormone receptor--positive metastatic breast cancer [corrected] [published erratum appears in ONCOLOGIST 2010 Mar;15(3):327].
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
In Reply.
- Published in:
- Oncologist, 2010, v. 15, n. 2, p. 214, doi. 10.1634/theoncologist.2009-0327
- By:
- Publication type:
- Article
Fixed-Dose-Rate Gemcitabine: A Viable First-Line Treatment Option for Advanced Pancreatic and Biliary Tract Cancer.
- Published in:
- Oncologist, 2010, v. 15, n. 2, p. 1E, doi. 10.1634/theoncologist.2008-0135
- By:
- Publication type:
- Article
Current Management of Gallbladder Carcinoma.
- Published in:
- Oncologist, 2010, v. 15, n. 2, p. 168, doi. 10.1634/theoncologist.2009-0302
- By:
- Publication type:
- Article
Predicting Response to EGFR Inhibitors in Metastatic Colorectal Cancer: Current Practice and Future Directions.
- Published in:
- Oncologist, 2010, v. 15, n. 2, p. 157, doi. 10.1634/theoncologist.2009-0221
- By:
- Publication type:
- Article
IDH1 Gene Mutations: A New Paradigm in Glioma Prognosis and Therapy?
- Published in:
- Oncologist, 2010, v. 15, n. 2, p. 196, doi. 10.1634/theoncologist.2009-0218
- By:
- Publication type:
- Article
Limited-Stage Small Cell Lung Cancer: Current Chemoradiotherapy Treatment Paradigms.
- Published in:
- Oncologist, 2010, v. 15, n. 2, p. 187, doi. 10.1634/theoncologist.2009-0298
- By:
- Publication type:
- Article
Why Doesn't Imatinib Cure Chronic Myeloid Leukemia?
- Published in:
- Oncologist, 2010, v. 15, n. 2, p. 182, doi. 10.1634/theoncologist.2009-0297
- By:
- Publication type:
- Article
Efficacy of Sunitinib in Advanced Medullary Thyroid Carcinoma: Intermediate Results of Phase II THYSU.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia.
- Published in:
- Oncologist, 2010, v. 15, n. 2, p. 200, doi. 10.1634/theoncologist.2009-0153
- By:
- Publication type:
- Article
Standard and Emerging Therapies for Metastatic Differentiated Thyroid Cancer.
- Published in:
- Oncologist, 2010, v. 15, n. 2, p. 146, doi. 10.1634/theoncologist.2009-0190
- By:
- Publication type:
- Article
Anti-Vascular Endothelial Growth Factor Therapies and Cardiovascular Toxicity: What Are the Important Clinical Markers to Target?
- Published in:
- Oncologist, 2010, v. 15, n. 2, p. 130, doi. 10.1634/theoncologist.2009-0252
- By:
- Publication type:
- Article
Lapatinib plus Letrozole as First-Line Therapy for HER-2<sup>+</sup> Hormone Receptor--Positive Metastatic Breast Cancer.
- Published in:
- Oncologist, 2010, v. 15, n. 2, p. 122, doi. 10.1634/theoncologist.2009-0240
- By:
- Publication type:
- Article
More Is Better: A Multimodality Approach to Cancer Cachexia.
- Published in:
- 2010
- By:
- Publication type:
- Editorial
Sorafenib Therapy for Hepatocellular Carcinoma in an HIV--HCV Coinfected Patient: A Case Report.
- Published in:
- 2010
- By:
- Publication type:
- Case Study